Qube Research & Technologies (QRT)
NVS icon

Qube Research & Technologies (QRT)’s Novartis NVS Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.85M Sell
43,740
-129,397
-75% -$19.4M 0.01% 1474
2026
Q1 		$26.4M Buy
173,137
+54,510
+46% +$8.36M 0.03% 720
2025
Q4 		$16.4M Sell
118,627
-70,840
-37% -$9.28M 0.02% 1027
2025
Q3 		$24.3M Buy
+189,467
New +$23.1M 0.03% 807
2025
Q2 		– Sell
-39,723
Closed -$4.48M – 3839
2025
Q1 		$4.43M Sell
39,723
-594,851
-94% -$63.3M 0.01% 1605
2024
Q4 		$61.8M Buy
634,574
+476,420
+301% +$50.8M 0.08% 312
2024
Q3 		$18.2M Sell
158,154
-17,329
-10% -$1.97M 0.03% 731
2024
Q2 		$18.7M Sell
175,483
-554,229
-76% -$55.6M 0.03% 628
2024
Q1 		$70.6M Buy
729,712
+385,402
+112% +$39.5M 0.11% 224
2023
Q4 		$34.8M Buy
344,310
+226,515
+192% +$21.9M 0.07% 351
2023
Q3 		$12M Sell
117,795
-87,989
-43% -$8.93M 0.03% 575
2023
Q2 		$20.8M Buy
+205,784
New +$20.6M 0.08% 334
2023
Q1 		– Sell
-165,124
Closed -$15M – 2874
2022
Q4 		$15M Buy
165,124
+49,736
+43% +$4.19M 0.08% 355
2022
Q3 		$8.77M Sell
115,388
-70,151
-38% -$5.82M 0.05% 443
2022
Q2 		$15.7M Buy
185,539
+141,326
+320% +$12.4M 0.12% 223
2022
Q1 		$3.88M Buy
+44,213
New +$3.83M 0.03% 579
2021
Q4 		– Sell
-103,144
Closed -$8.44M – 2843
2021
Q3 		$8.44M Sell
103,144
-1,080
-1% -$97.2K 0.11% 243
2021
Q2 		$9.51M Buy
104,224
+101,518
+3,752% +$9.04M 0.11% 219
2021
Q1 		$231K Buy
+2,706
New +$243K ﹤0.01% 1589
2020
Q4 		– Sell
-69,165
Closed -$6.01M – 2090
2020
Q3 		$6.01M Buy
69,165
+51,907
+301% +$4.5M 0.09% 304
2020
Q2 		$1.51M Buy
+17,258
New +$1.49M 0.02% 741
2020
Q1 		– Sell
-14,829
Closed -$1.4M – 1489
2019
Q4 		$1.4M Buy
+14,829
New +$1.33M 0.04% 483

Other funds holding NVS

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Qube Research & Technologies (QRT)'s NVS Position: Q2 2026 in Review

Qube Research & Technologies (QRT) reduced its Novartis (NVS) stake by 75% in Q2 2026, selling an estimated $19.4M and leaving 43,740 shares worth $6.85M. The position accounts for 0.01% of the portfolio, ranked #1474.

Qube Research & Technologies (QRT) first reported a position in NVS in Q4 2019 and has held it in 22 quarters since. The position peaked at $70.6M in Q1 2024. 1,619 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Qube Research & Technologies (QRT) held 43,740 shares of Novartis worth $6.85M as of Q2 2026.
  • Qube Research & Technologies (QRT) sold 129,397 Novartis shares in Q2 2026, an estimated $19.4M.
  • Novartis made up 0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #1474 holding.
  • Qube Research & Technologies (QRT) first reported a position in Novartis in Q4 2019 and has held it in 22 quarters since.
  • Qube Research & Technologies (QRT)'s Novartis position peaked at $70.6M in Q1 2024.
  • 1,619 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.